ConductScience.org, home

Comparison · NCT00004732-sae

Carotid-Artery Stenting vs Carotid Endarterectomy: serious adverse events

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Carotid-Artery Stenting vs Carotid Endarterectomy: serious adverse events. Trial comparisons, record NCT00004732-sae. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT00004732-sae

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.2550.2320.28wilson
Risk in group 20.2350.2130.26wilson
Risk difference, group 1 minus group 20.0197-0.01410.0533newcombe hybrid score
Risk ratio, group 1 over group 21.080.9441.24log
Odds ratio, group 1 over group 21.110.9271.33log
Number needed to harm, for one more participant with a serious adverse event on Carotid-Artery Stenting than on Carotid Endarterectomy50.8from the risk difference intervalthe interval includes no difference

Groups2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1Carotid-Artery StentingPatients Randomized to CAS3221,262EG000
Group 2Carotid EndarterectomyPatients Randomized to CEA2921,240EG001

Harm

What it counts
Total, serious adverse events
Time frame
Periprocedural period

Source ClinicalTrials.gov

Trial

Title
Carotid Revascularization Endarterectomy Versus Stenting Trial
NCT number
NCT00004732
Phases
NA
Conditions
Atherosclerosis, Stroke, Carotid Stenosis, Cerebral Infarction, Myocardial Infarction
Interventions
Carotid Endarterectomy (CEA), Carotid Artery Stenting (CAS)
Lead sponsor
Rutgers, The State University of New Jersey
Results first posted
2013-12-10

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT00004732-sae